vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Shutterstock, Inc. (SSTK). Click either name above to swap in a different company.
Shutterstock, Inc. is the larger business by last-quarter revenue ($220.2M vs $168.4M, roughly 1.3× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -12.0%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 1.4%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Shutterstock, Inc. is an American provider of stock photography, stock footage, stock music, and editing tools; it is headquartered in New York. Founded in 2002 by programmer and photographer Jon Oringer, Shutterstock maintains a library of around 200 million royalty-free stock photos, vector graphics, and illustrations, with around 10 million video clips and music tracks available for licensing. Originally a subscription site only, Shutterstock expanded beyond subscriptions into à la carte p...
ESPR vs SSTK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $220.2M |
| Net Profit | — | $-16.0M |
| Gross Margin | — | 55.8% |
| Operating Margin | 50.6% | -1.1% |
| Net Margin | — | -7.3% |
| Revenue YoY | 143.7% | -12.0% |
| Net Profit YoY | — | -1021.0% |
| EPS (diluted) | $0.32 | $-0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $220.2M | ||
| Q3 25 | $87.3M | $260.1M | ||
| Q2 25 | $82.4M | $267.0M | ||
| Q1 25 | $65.0M | $242.6M | ||
| Q4 24 | $69.1M | $250.3M | ||
| Q3 24 | $51.6M | $250.6M | ||
| Q2 24 | $73.8M | $220.1M | ||
| Q1 24 | $137.7M | $214.3M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $-31.3M | $13.4M | ||
| Q2 25 | $-12.7M | $29.4M | ||
| Q1 25 | $-40.5M | $18.7M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | $-29.5M | $17.6M | ||
| Q2 24 | $-61.9M | $3.6M | ||
| Q1 24 | $61.0M | $16.1M |
| Q4 25 | — | 55.8% | ||
| Q3 25 | — | 60.6% | ||
| Q2 25 | — | 60.3% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.1% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 58.8% |
| Q4 25 | 50.6% | -1.1% | ||
| Q3 25 | -11.4% | 12.5% | ||
| Q2 25 | 8.6% | 13.0% | ||
| Q1 25 | -34.0% | 4.2% | ||
| Q4 24 | -6.4% | 5.3% | ||
| Q3 24 | -31.0% | 7.2% | ||
| Q2 24 | 3.5% | 9.4% | ||
| Q1 24 | 52.5% | 7.8% |
| Q4 25 | — | -7.3% | ||
| Q3 25 | -35.9% | 5.1% | ||
| Q2 25 | -15.4% | 11.0% | ||
| Q1 25 | -62.2% | 7.7% | ||
| Q4 24 | — | -0.6% | ||
| Q3 24 | -57.2% | 7.0% | ||
| Q2 24 | -83.9% | 1.6% | ||
| Q1 24 | 44.3% | 7.5% |
| Q4 25 | $0.32 | $-0.47 | ||
| Q3 25 | $-0.16 | $0.37 | ||
| Q2 25 | $-0.06 | $0.82 | ||
| Q1 25 | $-0.21 | $0.53 | ||
| Q4 24 | $-0.14 | $-0.04 | ||
| Q3 24 | $-0.15 | $0.50 | ||
| Q2 24 | $-0.33 | $0.10 | ||
| Q1 24 | $0.34 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $178.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $581.0M |
| Total Assets | $465.9M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $178.2M | ||
| Q3 25 | $92.4M | $165.5M | ||
| Q2 25 | $86.1M | $116.4M | ||
| Q1 25 | $114.6M | $112.2M | ||
| Q4 24 | $144.8M | $111.3M | ||
| Q3 24 | $144.7M | $131.4M | ||
| Q2 24 | $189.3M | $74.9M | ||
| Q1 24 | $226.6M | $71.8M |
| Q4 25 | $-302.0M | $581.0M | ||
| Q3 25 | $-451.4M | $594.4M | ||
| Q2 25 | $-433.5M | $586.2M | ||
| Q1 25 | $-426.2M | $547.2M | ||
| Q4 24 | $-388.7M | $518.4M | ||
| Q3 24 | $-370.2M | $522.9M | ||
| Q2 24 | $-344.2M | $520.4M | ||
| Q1 24 | $-294.3M | $541.3M |
| Q4 25 | $465.9M | $1.4B | ||
| Q3 25 | $364.0M | $1.4B | ||
| Q2 25 | $347.1M | $1.4B | ||
| Q1 25 | $324.0M | $1.3B | ||
| Q4 24 | $343.8M | $1.3B | ||
| Q3 24 | $314.1M | $1.3B | ||
| Q2 24 | $352.3M | $1.0B | ||
| Q1 24 | $373.1M | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $36.2M |
| Free Cash FlowOCF − Capex | — | $25.9M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | 0.0% | 4.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $123.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $36.2M | ||
| Q3 25 | $-4.3M | $78.4M | ||
| Q2 25 | $-31.4M | $26.8M | ||
| Q1 25 | $-22.6M | $25.2M | ||
| Q4 24 | $-35.0M | $8.0M | ||
| Q3 24 | $-35.3M | $-11.6M | ||
| Q2 24 | $-7.2M | $28.0M | ||
| Q1 24 | $53.8M | $8.3M |
| Q4 25 | — | $25.9M | ||
| Q3 25 | — | $68.0M | ||
| Q2 25 | — | $15.5M | ||
| Q1 25 | — | $14.4M | ||
| Q4 24 | — | $-952.0K | ||
| Q3 24 | $-35.5M | $-26.3M | ||
| Q2 24 | $-7.3M | $18.9M | ||
| Q1 24 | $53.8M | $-6.2M |
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 26.1% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -0.4% | ||
| Q3 24 | -68.7% | -10.5% | ||
| Q2 24 | -9.9% | 8.6% | ||
| Q1 24 | 39.0% | -2.9% |
| Q4 25 | 0.0% | 4.7% | ||
| Q3 25 | 0.0% | 4.0% | ||
| Q2 25 | 0.0% | 4.2% | ||
| Q1 25 | 0.0% | 4.5% | ||
| Q4 24 | 0.0% | 3.6% | ||
| Q3 24 | 0.3% | 5.9% | ||
| Q2 24 | 0.1% | 4.1% | ||
| Q1 24 | 0.1% | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.86× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 1.35× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.66× | ||
| Q2 24 | — | 7.71× | ||
| Q1 24 | 0.88× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SSTK
Segment breakdown not available.
